101 related articles for article (PubMed ID: 12193943)
1. Gene expression profile of trisomy 21 placentas: a potential approach for designing noninvasive techniques of prenatal diagnosis.
Gross SJ; Ferreira JC; Morrow B; Dar P; Funke B; Khabele D; Merkatz I
Am J Obstet Gynecol; 2002 Aug; 187(2):457-62. PubMed ID: 12193943
[TBL] [Abstract][Full Text] [Related]
2. Measurement of allelic-expression ratios in trisomy 21 placentas by quencher extension of heterozygous samples identified by partially denaturing HPLC.
Go AT; Visser A; Betsalel OT; van Vugt JM; Blankenstein MA; Oudejans CB
Clin Chem; 2008 Feb; 54(2):437-40. PubMed ID: 18223136
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.
Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM
Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype.
Rozovski U; Jonish-Grossman A; Bar-Shira A; Ochshorn Y; Goldstein M; Yaron Y
Hum Reprod; 2007 Sep; 22(9):2538-45. PubMed ID: 17635843
[TBL] [Abstract][Full Text] [Related]
5. Microarray-Based Analysis of Methylation of 1st Trimester Trisomic Placentas from Down Syndrome, Edwards Syndrome and Patau Syndrome.
Hatt L; Aagaard MM; Bach C; Graakjaer J; Sommer S; Agerholm IE; Kølvraa S; Bojesen A
PLoS One; 2016; 11(8):e0160319. PubMed ID: 27490343
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide gene expression analysis in the placenta from fetus with trisomy 21.
Lim JH; Han YJ; Kim HJ; Kwak DW; Park SY; Chun SH; Ryu HM
BMC Genomics; 2017 Sep; 18(1):720. PubMed ID: 28899343
[TBL] [Abstract][Full Text] [Related]
7. A 3800 gene microarray for cattle functional genomics: comparison of gene expression in spleen, placenta, and brain.
Band MR; Olmstead C; Everts RE; Liu ZL; Lewin HA
Anim Biotechnol; 2002 May; 13(1):163-72. PubMed ID: 12212940
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.
Lim JH; Lee DE; Kim SY; Kim HJ; Kim KS; Han YJ; Kim MH; Choi JS; Kim MY; Ryu HM; Park SY
J Assist Reprod Genet; 2015 May; 32(5):827-37. PubMed ID: 25749789
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed miRNAs in trisomy 21 placentas.
Svobodová I; Korabečná M; Calda P; Břešťák M; Pazourková E; Pospíšilová Š; Krkavcová M; Novotná M; Hořínek A
Prenat Diagn; 2016 Aug; 36(8):775-84. PubMed ID: 27323694
[TBL] [Abstract][Full Text] [Related]
10. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study.
Tsui NB; Wong BC; Leung TY; Lau TK; Chiu RW; Lo YM
Prenat Diagn; 2009 Nov; 29(11):1031-7. PubMed ID: 19650060
[TBL] [Abstract][Full Text] [Related]
13. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment.
Bornstein E; Lenchner E; Donnenfeld A; Jodicke C; Keeler SM; Kapp S; Divon MY
Am J Obstet Gynecol; 2010 Oct; 203(4):391.e1-5. PubMed ID: 20691415
[TBL] [Abstract][Full Text] [Related]
14. [Rapid detection of the most common chromosomal aneuploidies in the second-trimester amniotic fluid using QF-PCR].
Švecová I; Burjanivová T; Kršiaková J; Lasabová Z; Biringer K; Kapustová I; Móricová P; Danko J
Ceska Gynekol; 2013 Aug; 78(4):373-8. PubMed ID: 24040987
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies.
Huang X; Zheng J; Chen M; Zhao Y; Zhang C; Liu L; Xie W; Shi S; Wei Y; Lei D; Xu C; Wu Q; Guo X; Shi X; Zhou Y; Liu Q; Gao Y; Jiang F; Zhang H; Su F; Ge H; Li X; Pan X; Chen S; Chen F; Fang Q; Jiang H; Lau TK; Wang W
Prenat Diagn; 2014 Apr; 34(4):335-40. PubMed ID: 24357023
[TBL] [Abstract][Full Text] [Related]
16. [Noninvasive prenatal screen of trisomy-21 using maternal plasma fetal free RNA allelic ratio].
Xu Y; Zhai S; Luo X; Zhang Y; Ran L; Ren L
Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):568-75. PubMed ID: 26675178
[TBL] [Abstract][Full Text] [Related]
17. A novel method to identify syncytiotrophoblast-derived RNA products representative of trisomy 21 placental RNA in maternal plasma.
Go AT; Visser A; van Dijk M; Mulders MA; Eijk P; Ylstra B; Blankenstein MA; van Vugt JM; Oudejans CB
Methods Mol Biol; 2008; 444():291-302. PubMed ID: 18425490
[TBL] [Abstract][Full Text] [Related]
18. C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma.
Go AT; Visser A; Mulders MA; Twisk JW; Blankenstein MA; van Vugt JM; Oudejans CB
Prenat Diagn; 2007 Feb; 27(2):146-9. PubMed ID: 17186567
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of placental neuropilin-1 in fetal growth restriction.
Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetuses.
Zedníková I; Chylíková B; Šeda O; Korabečná M; Pazourková E; Břešťák M; Krkavcová M; Calda P; Hořínek A
Mol Biol Rep; 2020 Jun; 47(6):4531-4540. PubMed ID: 32472298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
